JAI PATEL: Open Payments
NPI 1366939696 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 11 payments from 4 companies in 2025. Trend: 2023 $405 · 2024 $230 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $141 |
| Alkermes, Inc. | 2 | $99 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: TEFLARO, LYBALVI, COBENFY, ARISTADA, ABILIFY MAINTENA, EMBLAVEO.
Industry payments across TX — which companies pay providers there.
